<DOC>
	<DOCNO>NCT00613561</DOCNO>
	<brief_summary>The hypothesis study child severe primary immunodeficiency benefit early stem cell transplantation utilize reduce intensity condition regimen . This regimen associate low risk complication lead correction underlying immunological defect .</brief_summary>
	<brief_title>Early Diagnosis Stem Cell Transplantation Severe Immunodeficiency Diseases</brief_title>
	<detailed_description />
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Busulfan</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<criteria>Must show one follow disease : SCIDS HyperIgM WiskottAldrich Syndrome ChediakHigashi Griscelli Syndromes XLinked Lymphoproliferative Diseases IPEX Syndrome NEMO Syndrome severe immunodeficiency disease state discretion Principal Investigator Informed Consent Adequate Renal Function Adequate Liver Function Adequate Cardiac Function Adequate Pulmonary Function Adequate Performance Statue Adequate Venous Access Patient/Family sign informed consent Patient clear diagnosis severe immunodeficiency disease A suitable donor patient find Patient HIV positive Patient active Hepatitis B Patient pregnant Patient consider unsuitable transplant discretion Principal Investigators medical director</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Patients Severe Immunodeficiency disease</keyword>
	<keyword>Severe Immunodeficiency disease</keyword>
</DOC>